Pure Global AI
ANVISA registration 80146502421Valid until May 04, 2036

TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)

ANVISA Registration Number: 80146502421ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT GMBHRisk Class IV
Verified
Device names
Technical name
TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
View exact technical-name matches →
PT: ANTICORPO TOTAL PARA VÍRUS DE HEPATITE C (ANTI-HCV)
Commercial name
Família Alinity i Anti-HCV Next
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
80146502421
Process Number
25351232964202522
CNPJ
56998701000116
Company information
Registration Holder
ABBOTT LABORATORIOS DO BRASIL LTDA
Manufacturer
ABBOTT GMBH
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
May 04, 2026
Validity
04/05/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502421 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until May 04, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.